Qualification：

Patent Attorney since 2000

Technical Field：

Food science and technology、Medicine & Pharmaceuticals、Life Sciences & Healthcare

Languages：

Chinese、English

Education and Training：

Ph.D. , Microbial Pharmaceuticals, Peking Union Medical College, 1995-1998

Master of technology, Biochemical Engineering, Dalian University of Science and Technology, 1992-1995

Bachelor of science, Microbiology, Shandong University in 1988-1992

Training course of US IP law and patent prosecution at Connolly Bove Lodge & Hutz (KBLH) , USA, 2005

Training course of US Intellectual Property law at Birch, Stewart, Kolasch & Birch (BSKB), USA, 2002

Professional Experience：

Deputy Director of Business Development Department of CCPIT Patent & Trademark Law Office from 2012 to present

Deputy Director of Domestic Patent Department of CCPIT Patent & Trademark Law Office from 2006 to 2012

Patent attorney in Chemical Department of CCPIT patent & Trademark Law Office from 1998-2006

Joined CCPIT Patent & Trademark Law Office since 1998;

Practice Area：

Drafting Patent Application Documents、Patent prosecution (including domestic patent application, PCT application and foreign patent application、Patent Reexamination、Patent Invalidation、Patent validity Litigation、Patent Infringement Litigation、Legal Opinion on Patent Infringement、Administrative Protection of Patent Right、Licensing/Assignment of Patent、Patent Search、Patent portfolio management、FTO Opinion、Third-party Observation/Public Opinion、Patent Landscape、Patent Watch、Patent mining、Patent strategy design、Intellectual property training

IP protection at trade shows、Infringement risks analysis、IP infringement analysis、IP infringement investigation、IP due diligence investigation、IP contract drafting and reviewing、Risk management and damage control、Consulting on IP strategy

Affiliation：

Chinese Group of AIPPI

All China Patent Agents Association

China Intellectual Property Society

Publication and Presentation：

Publication
Co-author, "Patent Agency Professional Ethics", Intellectual Property Press, 2013 ;
Co-author, "Guide to Training Practitioners in Patent Agency Industry", Intellectual Property Press, 2008.

Article
Author, " Thoughts triggered by the substantial reduction of the patent authorization time", December 2019, IPR Daily;
Co-author, "The drug patent linkage system is emerging, how do generic drugs respond", November 2017, IPR Daily
Author, "Thinking about the Internet Disclosure of Examination Information of Invention Patent Applications Before Grant", "Patent Agency" (CN10-1332/TB) Issue 2, p55-57; May 2016;

Presentation
Intellectual Property Protection Issues along the "One Belt and One Road", "One Belt One Road" International Technology Transfer and Development Conference in Xi'an, China, Xi'an, Shaanxi, December 2019;
"Overseas Intellectual Protection in the time of Trade Friction", "Corporate International Trade Compliance Management and Overseas Intellectual Property Protection", Ordos, Inner Mongolia, November 2019;
"Intellectual Property Services Promote the Construction of Science and Technology Innovation Centers", China (Beijing) International Service Trade Exhibition Intellectual Property Forum, Beijing, May 2019;
"Protection of Intellectual Property Rights in Overseas Investment", UK-China Business Forum and the 6th China Overseas Investment Conference, Shanghai, November 2018;
"Enterprise Intellectual Property Management and Patent Application Strategies", Overseas Intellectual Property Protection Seminar, Ningbo, Zhejiang, September 2011;
"Patent Application Practice in the Field of Medicine and Biology", China Patent Information Annual Conference, Beijing, September 2011;
"Patent Mining Practice", Sino-US Patent and Trademark System Seminar, Foshan, Guangdong, November 2010;
"Disclosure Requirements on Source of Genetic Resources in Patent Application in China”, SIPO-USPTO Joint Seminar, Beijing, September 2010;
“Genetic Resources Requirements in the new Chinese Patent Law”, the 5th Sino-US Enterprise Intellectual Property Seminar, Beijing, October 2009;
"The Enlightenment of Patent Litigation of Multinational Pharmaceutical Companies on Patent Protection in the Pharmaceutical Industry", China Medical Association Symposium on Drug Patent Strategy Application, Beijing, October 2009;
"Prevention of Intellectual Property Risks of Products Exhibited in Exhibitions", China International Chamber of Commerce Overseas Intellectual Property Protection Seminar, Beijing, June 2009;
"Enterprises' Strategies for Dealing with International Intellectual Property Disputes", China Automotive Industry Intellectual Property Seminar, Beijing, December 2007;
"Enterprise Patent Protection Strategy", Intellectual Property Protection Forum of the 7th Western China Expo, Chengdu, Sichuan, May 2006.

Representative Cases：

"Hepatitis E Virus Monoclonal Antibody and Its Use" (Patent No.: ZL02822218.0) of Xiamen University， Fourteenth China Invention Patent Gold Award issued by the State Intellectual Property Office in 2012.